Risks associated with sunitinib use and monitoring to improve patient outcomes.
10.3904/kjim.2014.29.1.23
- Author:
Bum Soon CHOI
1
Author Information
1. Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea. sooncb@catholic.ac.kr
- Publication Type:Comment ; Editorial
- MeSH:
Antineoplastic Agents/*adverse effects;
Female;
Humans;
Indoles/*adverse effects;
Male;
Proteinuria/*chemically induced;
Pyrroles/*adverse effects;
Renal Insufficiency/*chemically induced
- From:The Korean Journal of Internal Medicine
2014;29(1):23-26
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
